Shimadzu has introduced its Method Package for Primary Metabolites, designed for the simultaneous analysis of a variety of metabolites associated with central metabolic pathways. Unlike current techniques, such as CE/MS, derivatization followed by GC/MS, or HILIC LC/MS, Shimadzu’s new package allows simultaneous analysis of a wider range of compounds. The new LC/MS/MS Method Package for […]
SANTA CLARA, Calif. — Agilent Technologies Inc. (NYSE: A) today announced plans to separate into two publicly traded companies: one in life sciences, diagnostics and applied markets (LDA) that will retain the Agilent name, and the other that will be comprised of Agilent’s current portfolio of electronic measurement (EM) products. The separation is expected to […]
SANTA CLARA, Calif. — Agilent Technologies Inc. (NYSE: A) today announced it has combined its Life Sciences Group with its Diagnostics and Genomics business, naming Lars Holmkvist the new group’s president and senior vice president of Agilent, effective immediately. Holmkvist was previously president of the Diagnostics and Genomics Group and senior vice president of Agilent. […]
SAVANNAH, Ga. — Protea Biosciences Group, Inc. (“Protea”) announced today that it has entered into a Collaborative Research Agreement with Virginia Commonwealth University (“VCU”) and its Center for Molecular Imaging. The research focuses on the combination of LAESI, Protea’s ex vivo molecular imaging mass spectrometry technology platform, with VCU’s in vivo molecular PET, SPECT and […]
Tokyo, JAPAN – Mitsubishi Chemical Medience Corporation (MCM) today announced that the company enters into an exclusive license agreement of Energy Resolved Oxonium Ion Monitoring (Erexim) Technology [PATPEND], jointly-developed by RIKEN (RIKEN) and Shimadzu Corporation (Shimadzu), in glycomics analysis services. By use of Erexim technology, MCM starts up evaluating the usefulness of Glycomics Analysis Services […]
Mitsubishi Chemical Medience (MCM) announced that the company enters into an exclusive license agreement of Energy Resolved Oxonium Ion Monitoring (Erexim) Technology [PATPEND], jointly-developed by RIKEN and Shimadzu, in glycomics analysis services. By use of Erexim technology, MCM starts up evaluating the usefulness of Glycomics Analysis Services for guiding development and quality management of glycosylated […]
LONDON, UNITED KINGDOM — Matrix Science today introduced Mascot Insight, a powerful softwareplatform for organizing, visualizing, and comparing proteomics datasets derived from mass spectrometry results. Leveraging the MascotServer search engine for protein identification, Mascot Insightenables meaningful conclusions to be drawn about changes within orbetween biological samples. The platform will address the needs ofresearchers in academia […]
YOKOHAMA, HUPO — Less than four months after introducing important new core “Tribrid” and triple quadrupole liquid chromatography-mass spectrometry (LC-MS) platforms built to transform customers’ work with unprecedented performance and ease of use, Thermo Fisher Scientific introduces two additional systems designed to advance intact protein analysis and “quanfirmation.” The new technology will be displayed at […]
Markes International (Llantrisant, UK) has announced that its worldwide thermal desorption and mass spectrometry business is set to expand into Germany. The German Technical Centre (Markes International GmbH) is located in Neu-Isenburg near Frankfurt and features a state-of-the-art laboratory for customer demonstrations and the development of new analytical procedures. There is also a conference room […]
Boston, MA: 908 Devices, an innovator in point-of-need chemical analysis, today announced that it received $7M in Series B funding, which included new investment from Schlumberger and follow-on investments from ARCH Venture Partners, Razor’s Edge Ventures and University of Tokyo Edge Capital (UTEC). In addition, 908 Devices and Schlumberger signed a technical collaboration and development […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
